Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Optinose Inc
(NQ:
OPTN
)
0.9265
-0.0052 (-0.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Optinose Inc
< Previous
1
2
3
4
5
Next >
OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
OPTN stock results show that OptiNose beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
August 08, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
August 02, 2024
Conference Call and Webcast to be held August 8, 2024, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
July 02, 2024
Check out these explosive penny stocks with massive growth potential that could turn a modest $10,000 investment into a life-changing $1 million.
Via
InvestorPlace
OptiNose's Earnings: A Preview
March 06, 2024
Via
Benzinga
Expanded Access to XHANCE with Addition to National Commercial Formularies
June 27, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
May 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
OPTN stock results show that OptiNose missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
May 14, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
May 10, 2024
Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces $55 Million Registered Direct Offering
May 09, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
April 25, 2024
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Are Stocks Down Today?
April 25, 2024
Stocks are down today and investors wondering why have come to the right place as we have all the news on the market drop on Thursday.
Via
InvestorPlace
Why Is OptiNose (OPTN) Stock Up 12% Today?
April 25, 2024
OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning.
Via
InvestorPlace
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024
Conference Call and Webcast to be held April 25, 2024, at 10:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
Optinose to Present at the Needham Virtual Healthcare Conference
April 04, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024
From
Optinose, Inc.
Via
GlobeNewswire
OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
March 07, 2024
OPTN stock results show that OptiNose met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
March 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
February 29, 2024
Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
January 18, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.